XOMA Corporation (XOMA)

Name: XOMA Corporation (XOMA) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: XOMA Corporation (XOMA)

Stock Card

$40.17

$0.00 (0.00%)

As on 21-Jul-2026 09:30EDT

Market cap

$710 Mln

Revenue (TTM)

$36 Mln

P/E Ratio

25.6

P/B Ratio

6.3

Div. Yield

0 %

XOMA (XOMA) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 40.17 High: 40.17

52 Week Range

Low: 22.30 High: 45.20

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

14.9
Debt to Equity

0.8
Book Value

$--
EPS

$1.8
Face value

--
Shares outstanding

17,678,742

10 Years Aggregate

CFO

$-151.37 Mln

EBITDA

$-166.68 Mln

Net Profit

$-147.72 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
XOMA (XOMA)	51.1	-4.1	0.4	56.5	35.1	4.4	13.3
BSE Sensex^*	-10.7	-3.7	1.8	-6.4	4.5	5.3	10.1
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 21-Jul-2026 | *As on 08-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
XOMA (XOMA)	1.2	41.6	0.5	-11.8	-52.8	61.6	115.8
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
XOMA (XOMA)	40.2	710.2	36.2	31.5	129.3	28.5	25.6	6.3
Arrowhead Pharmaceuticals (ARWR)	85.1	12,161.6	669.5	-320.0	-0.8	-71.1	--	26.2
Ascendis Pharma A/S - ADR	270.1	17,746.8	1,054.4	755.9	5.7	--	20.9	10.5
Cytokinetics Inc (CYTK)	75.4	10,109.8	71.0	-894.0	-1,175.8	--	--	60.5
Exelixis (EXEL)	57.7	14,621.6	2,435.9	860.6	31.0	43	18.6	7.9
Halozyme Therapeutics (HALO)	108.3	12,506.3	1,663.7	413.6	36.3	430	32.3	86.7
Krystal Biotech (KRYS)	351.3	10,603.5	440.5	241.5	33.4	18.7	44.9	8.1
Madrigal Pharmaceuticals (MDGL)	534.2	12,501.2	1,283.9	-325.1	-19.0	-57.7	--	23.9
Medpace Holdings (MEDP)	590.9	16,503.9	2,782.3	491.5	21.1	110.1	34.7	38.2
Nuvalent Inc (NUVL)	124.0	9,808.7	0.0	-450.1	--	-44.6	--	8.4

Shareholding Pattern

View Details

About XOMA (XOMA)

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial... products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated. Read more

CEO & Director

Mr. Owen P. Hughes Jr.
CEO & Director

Mr. Owen P. Hughes Jr.
Headquarters

EmeryVille, CA
Website

https://www.xoma.com

FAQs for XOMA (XOMA)

What is the current share price of XOMA Corporation (XOMA) Today?

The share price of XOMA Corporation (XOMA) is $40.17 (NASDAQ) as of 21-Jul-2026 09:30 EDT. XOMA Corporation (XOMA) has given a return of 35.07% in the last 3 years.

What is the current PB & PE ratio of XOMA Corporation (XOMA)?

The P/E ratio of XOMA Corporation (XOMA) is 25.59 times as on 21-Jul-2026.
The P/B ratio of XOMA Corporation (XOMA) is 6.29 times as on 21-Jul-2026, a 18 premium to its peers’ median range of 5.33 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	15.17	4.63
2024	-22.53	3.80
2023	-5.20	2.39
2022	-12.32	1.70
2021	15.94	1.78

What is the 52 Week High and Low of XOMA Corporation (XOMA)?

The 52-week high and low of XOMA Corporation (XOMA) are Rs 45.20 and Rs 22.30 as of 09-Sep-2026.

What is the market cap of XOMA Corporation (XOMA)?

XOMA Corporation (XOMA) has a market capitalisation of $ 710 Mln as on 21-Jul-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in XOMA Corporation (XOMA)?

Before investing in XOMA Corporation (XOMA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.